A double-blind, placebo-controlled, randomized, multicenter study to investigate CHInese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study)

International Journal of Stroke

Volumn 4, Issue 1, 2009, Pages 54-60

  Venketasubramanian, N ^a   Chen, C L H ^b   Gan, R N ^c   Chan, B P L ^a   Chang, H M ^c   Tan, S B ^d   Picard, D ^e   Navarro, J C ^f   Baroque Ii, A C ^f   Poungvarin, N ^g   Donnan, G A ^h   Bousser, M G ⁱ  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^d Clinical Trials and Epidemiology Research Unit   (Singapore)

^e Moleac Pte Ltd   (Singapore)

^f UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

^g MAHIDOL UNIVERSITY   (Thailand)

^h FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

ⁱ HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Acute stroke therapy; Asia; Cerebral infarction; Ischemic stroke; Therapy; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ACORI TATARINOWII EXTRACT; ANGELICA SINENSIS EXTRACT; ANTICOAGULANT AGENT; ASTRAGALUS EXTRACT; CHINESE DRUG; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; HEPARIN; HEPARINOID; LIGUSTICUM CHUANXIONG EXTRACT; LOW MOLECULAR WEIGHT HEPARIN; NEUROAID; PAEONIA RADIX; PLACEBO; PLANT EXTRACT; POLYGALAE EXTRACT; PRUNUS PERSICA EXTRACT; SAFFLOWER EXTRACT; SALVIA MILTIORRHIZA EXTRACT; TICLOPIDINE; UNCLASSIFIED DRUG;

ACORI TATARINOWII; ARTICLE; BARTHEL INDEX; BLOOD CELL COUNT; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ELECTROCARDIOGRAM; HUMAN; KIDNEY FUNCTION; LEECH; LIVER FUNCTION; MAJOR CLINICAL STUDY; MEDICINAL PLANT; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; OUTCOME ASSESSMENT; POLYGALACEAE; PRIORITY JOURNAL; PRUNUS PERSICA; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SCORPION;

DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; NEUROPROTECTIVE AGENTS; RESEARCH DESIGN; STROKE;

EID: 60549101099     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2009.00237.x     Document Type: Article

References (10)

1. Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet 1997; 349: 1436-42.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-7.
3. Vahedi K, Hofmeijer J DECIMAL, DESTINY, and HAMLET investigators et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6:215-22.
4. Chen ZM, Sandercock P, Pan HC et al. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40000 randomized patients from the Chinese acute stroke trial and the international stroke trial. Stroke 2000; 31:1240-9.
5. Stroke Unit Trialists' Collaboration: Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev October 17, 2007;(4):CD0001975.
6. Tang Q: Clinical study report on efficiency of Danqi Piantan capsule in the treatment of apoplexy due to deficiency of qi and stasis of blood syndrome. Zhong Guo Zhong Yi Yao Ke Ji 2003; 10:69-71.
7. Pan YT: Curative effect observation of Naoxintong capsule on treating cerebral infarction patients. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2003; 1:493-4.
8. Wang DM, Zhong GQ: Curative effect analysis of Buchang Naoxintong capsule on treating cerebral infarction patients. Si Chuan Yi Xue 2002; 23:863.
9. Gan R, Lambert C, Jiao LT et al. Danqi Piantan Jiaonang does not modify hemostasis, hematology, and biochemistry in normal subjects and stroke patients. Cerebrovasc Dis 2008; 25: 450-6.
10. Wong KS, Chen C, FISS-Tris Study Investigators et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: A randomised study. Lancet Neurol 2007; 6: 407-13.